GLP-3 Receptor Agonist Analog (RTA designation – Retatrutide analog) is available as lyophilized powder in 5mg vials for triple incretin receptor agonist research and multi-target endocrine investigation. This novel triple receptor agonist (GLP-1/GIP/GCG) provides unique research capacity for comprehensive metabolic signaling evaluation.

Chemical Composition:

• Chemical Name: Triple Incretin Receptor Agonist Analog (GLP-1/GIP/GCG)
• Molecular Formula: C206H324N56O61S8 (representative structure)
• Molecular Weight: ~4,727 g/mol (approximate)
• Compound Class: Tripeptide receptor agonist; incretin-glucagon dual target compound

This triple incretin receptor agonist analog simultaneously activates GLP-1, glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptor signaling pathways, enabling investigation of combined metabolic effects exceeding single-receptor activation. The 5mg dosage supports initial characterization of triple-agonist activity and baseline receptor engagement studies. Research applications encompass evaluation of combinatorial effects on glucose homeostasis, investigation of synergistic insulin secretion enhancement compared to selective receptor agonists, assessment of hepatic glucose production regulation through dual GLP-1/GCG signaling, and preclinical efficacy evaluation in obesity and metabolic dysfunction models.

Research Applications:

• Glucose-stimulated insulin secretion (GSIS) comparison: single vs. triple agonists
• Triple receptor binding affinity and selectivity profiling across GLP-1/GIP/GCG targets
• Hepatic glucose output suppression assessment in perfused liver models
• Synergistic effects analysis on incretin hormone potentiation and glucose regulation
• Comparative metabolic efficacy evaluation in insulin-resistant animal models

Storage and Handling:

• Store lyophilized powder at -20°C in sealed, light-protected vials
• Maintain desiccated conditions; prevent moisture and humidity exposure
• Reconstitute with sterile, endotoxin-free water for injection
• Solution stability: 7 days at 4°C once reconstituted

Product Specifications:

• Form: Lyophilized powder
• Quantity: 5mg per vial
• Purity: >95% by HPLC
• Appearance: White lyophilized cake

FOR RESEARCH USE ONLY. Not intended for human consumption or clinical use. All products are sold strictly for laboratory, educational, and scientific research purposes.